PT  - JOURNAL ARTICLE
AU  - Bhattarai, Kritib
AU  - Das, Trisha
AU  - Kim, Yejin
AU  - Chen, Yongbin
AU  - Dai, Qiying
AU  - Li, Xiaoyang
AU  - Jiang, Xiaoqian
AU  - Zong, Nansu
TI  - Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer’s Disease
AID  - 10.1101/2023.01.26.23285064
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.01.26.23285064
4099  - http://medrxiv.org/content/early/2023/01/29/2023.01.26.23285064.short
4100  - http://medrxiv.org/content/early/2023/01/29/2023.01.26.23285064.full
AB  - Background Alzheimer’s Disease (AD) is a progressive neurological disorder with no specific curative medications. While only a few medications are approved by FDA (i.e., donepezil, galantamine, rivastigmine, and memantine) to relieve symptoms (e.g., cognitive decline), sophisticated clinical skills are crucial to optimize the appropriate regimens given the multiple coexisting comorbidities in this patient population.Objective Here, we propose a study to leverage reinforcement learning (RL) to learn the clinicians’ decisions for AD patients based on the longitude records from Electronic Health Records (EHR).Methods In this study, we withdraw 1,736 patients fulfilling our criteria, from the Alzheimer’s Disease Neuroimaging Initiative(ADNI) database. We focused on the two most frequent concomitant diseases, depression, and hypertension, thus resulting in five main cohorts, 1) whole data, 2) AD-only, 3) AD-hypertension, 4) AD-depression, and 5) AD-hypertension-depression. We modeled the treatment learning into an RL problem by defining the three factors (i.e., states, action, and reward) in RL in multiple strategies, where a regression model and a decision tree are developed to generate states, six main medications extracted (i.e., no drugs, cholinesterase inhibitors, memantine, hypertension drugs, a combination of cholinesterase inhibitors and memantine, and supplements or other drugs) are for action, and Mini-Mental State Exam (MMSE) scores are for reward.Results Given the proper dataset, the RL model can generate an optimal policy (regimen plan) that outperforms the clinician’s treatment regimen. With the smallest data samples, the optimal-policy (i.e., policy iteration and Q-learning) gained a lesser reward than the clinician’s policy (mean -2.68 and -2.76 vs. -2.66, respectively), but it gained more reward once the data size increased (mean -3.56 and -2.48 vs. -3.57, respectively).Conclusions Our results highlight the potential of using RL to generate the optimal treatment based on the patients’ longitude records. Our work can lead the path toward the development of RL-based decision support systems which could facilitate the daily practice to manage Alzheimer’s disease with comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a grant from the National Institute of Health (NIH) NIGMS (R00GM135488).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://adni.loni.usc.edu/data-samples/access-data/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://adni.loni.usc.edu/data-samples/access-data/